Answers are grounded in this paper and cite their sources.
Experimental study demonstrates selective protein kinase C inhibition in platelets and T cells, indicating potential immunosuppressive therapeutic utility.
A series of potent, selective inhibitors of protein kinase C has been derived from the structural lead provided by the microbial broth products, staurosporine and K252a. Our inhibitors block PCK in intact cells (platelets and T cells), and prevent the proliferation of mononuclear cells in response to interleukin 2 (IL2).
No takes yet. Share an insight, caveat, or question.
Davis et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: